MDMA (Methylenedioxymethamphetamine) is a favorite psychoactive substance found in the recreational drug Ecstasy.
The real health concern it sounds isn’t in the short-term dangers of MDMA. But instead the alarmingly large number of habitual and long-term users of MDMA who often knock their hormones out of whack, every single weekend. This long-term abuse is stressing because MDMA is now a somewhat new drug and as such, there has been no research on long-term MDMA users.
MDMA has a very distinctive basis of mechanism – significantly altering the serotonin systems of the mind
The additional recent study conducted on both non-invasive primates and humans has found differences between MDMA user’s brains and performance steps compared to non-MDMA users. Its main release of serotonin is reportedly the cause of the majority of Ecstasy’s positive side effects, the depression users believe after using the drug as well as the neurotoxic changes found in MDMA user’s brains. These impacts are as no surprise, as dopamine is that the neurotransmitter was primarily responsible for regulating stress, sleep, and disposition. Present research on MDMA and also the mind has attracted conflicting and intricate results.
Animal research has demonstrated much research on MDMA and possible harmful effects it has on the individual soul
There’s a massive library of literature demonstrating differences in memory, language, and brain function between MDMA users and non-users; along with anti-inflammatory experiments showing irregular serotonin axon regrowth in many close genetic relatives. But a lot of the current research suffers from poor experimental design and experimental controllers that are central to some scientific study and too intensely associated correlation with causation.
Most research on how ecstasy users can be categorized into two areas of study
Neurofunctional measures and neurocognitive measures. Neurofunctional is loosely used to indicate steps of how the brain is functioning and standards of the concentration or density of neurochemicals. Neurocognitive steps describe performance on standardized psychological tests of cognitive skills. Research on ecstasy users affirms relationships involving MDMA exposure and alterations in both neurofunctional and neurocognitive measures.